Friday 6 November 2026 Export UTHR’s income statement to Excel — free account

United Therapeutics Corporation

UTHR Healthcare Drug Manufacturers Specialty & Generic

United Therapeutics Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 10.6% from fiscal 2024.

Revenue: +4.13%
EPS: −21.7%
Free cash flow: −63.7%

Quarter to September 2026, against a year earlier

561.51 4.21 −0.74%

Follow UTHR

Alert me

Market cap: $24.3B
P/E: 19.7×
Fwd P/E: 22.5×
Dividend yield: —
F-score: 8/9
Altman Z: 19.55
Beneish M: −2.26
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	8	7	6	6
ROE Full definition →		19.71%	20.26%	19.32%	19.13%
ROA Full definition →		17.51%	17.81%	17.33%	17.11%
ROIC Full definition →		22.34%	23.94%	23.44%	30.13%
Return on Tangible Assets Full definition →		27.40%	31.30%	27.28%	44.31%
Average Days of Receivables Full definition →		40.16	35.93	35.90	0.00
Free Cash Flow per Share Full definition →		23.37	23.38	25.66	20.31
Free Cash Flow Full definition →		1,035.20	1,016.90	1,093.00	867.20
Capital Expenditures Full definition →		(526.00)	(546.40)	(592.20)	(562.40)
Other line items
Cash ROIC Full definition →		10.33%	12.62%	12.06%	8.84%
Accounts Receivable Turnover Full definition →		10.11	10.00	9.15	9.86
Accounts Payable Turnover Full definition →		0.92	0.98	0.94	0.88
Inventory Turnover Full definition →		2.25	2.47	2.41	2.30
Average Days of Payables Full definition →		463.37	427.65	415.59	0.00
Days of Inventory on Hand Full definition →		173.86	153.02	161.80	0.00
Tax Rate Full definition →		(0.22)	(0.20)	(0.17)	(0.18)
Research and Development Expense of Revenue Full definition →		17.28%	17.01%	17.48%	22.06%
Selling, General and Administrative Expense of Revenue Full definition →		23.75%	24.29%	24.22%	22.83%
Share Based Compensation of Revenue Full definition →		4.64%	4.73%	4.93%	4.93%
Interest Coverage Full definition →		76.54	87.53	116.82	111.02
Operating CF/Net income Full definition →		1.17	1.21	1.29	1.16
Depreciation/Fixed assets Full definition →		0.05	0.05	0.05	0.00
Capex/Depreciation Full definition →		(6.14)	(6.18)	(6.47)	(5.86)
Revenue per Share Full definition →		71.84	72.87	74.05	74.65
Operating CF per Share Full definition →		35.24	35.94	39.56	33.48
Capex per Share Full definition →		(11.87)	(12.56)	(13.90)	(13.17)
Capex to Sales Full definition →		0.17	0.17	0.19	0.18

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly